NRX Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
NRXP NRX Pharmaceuticals Inc
$NQDM15LMCADN Nasdaq Developed Markets Telecommuni
BFZ BlackRock California Municipal Income Trust
CAR Avis Budget Group Inc
GIS General Mills Inc
VLN Valens Semiconductor Ltd
CIF MFS? Intermediate High Income Fund
LVOXW LiveVox Holdings Inc *W EXP 06/18/2026
SASR Sandy Spring Bancorp Inc
SWKH SWK Holdings Corp
Go

Health Care : Pharmaceuticals |
Company profile

NRX Pharmaceuticals, Inc., formerly Big Rock Partners Acquisition Corp., is a patient-focused, clinical stage pharmaceutical company. The Company is focused on developing NRX-101. NRX-101 is an oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder and ZYESAMI (aviptadil), an intravenous and inhaled drug to treat respiratory failure in COVID-19. NRX-101 is designed to offer an oral, rapid-onset and sustained home-use therapy that can extend ketamine’s anti-suicidal benefit and reduce the side effects of ketamine. The Company combines D-cycloserine (DCS), a N-methyl-D-aspartate (NMDA) receptor modulator, and lurasidone, a 5-HT2a receptor antagonist. NRX-101 is in Phase III of clinical testing.

Closing Price
$10.26
Day's Change
-1.65 (-13.85%)
Bid
--
Ask
--
B/A Size
--
Day's High
11.45
Day's Low
10.14
Volume
(Light)
Volume:
4,655,678

10-day average volume:
8,700,627
4,655,678
  • Prev Close
    11.91
  • Today's Open
    11.12
  • Day's Range
    10.14-11.45
  • Avg Vol (10-day)
    8.7M
  • Last (time)
    4:00p ET 10/15/21
  • Last (size)
    1
  • 52-Wk Range
    6.43 - 76.99
    LowHigh
  • (12/22/20 - 10/11/21)
    59.68%
  • 190.6%
  • Market Cap
    551.7M
  • Shares Outstanding
    53.8M
  • -7.60
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.3
  • 3.05
  • (% of float 09/30/21)
    9.03

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.